Results 151 to 160 of about 825 (170)

Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex

European Journal of Pharmacology, 2011
Motohiro Okada, Hisashi Tanii, Satoshi Yamamura   +2 more
exaly  

Blonanserin

2015
openaire   +1 more source

The position of blonanserin as a treatment for schizophrenia

Asia-Pacific Psychiatry, 2014
Taro Kishi, Yuki Matsuda, Nakao Iwata
openaire   +1 more source

Delusional Infestation Responding to Blonanserin

The Journal of Neuropsychiatry and Clinical Neurosciences, 2013
M.S. Bhatia, Anubhav Rathi, Anurag Jhanjee   +2 more
openaire   +1 more source

role of blonanserin in cannabis-induced psychosis

European Neuropsychopharmacology, 2016
D. Pan, A. Mallik, S. Chakraborty, T. Sur   +3 more
openaire   +2 more sources

Evaluation of dopamine D3 receptor occupancy by blonanserin using [11C]-(+)-PHNO in schizophrenia patients

Psychopharmacology, 2020
Ryosuke Arakawa, Amane Tateno, Takeshi Sakayori   +2 more
exaly  

Blonanserin-Associated Leukopenia

Journal of Clinical Psychopharmacology
Ruyi Zhang, Jia Liu, Shanshan Wang, Dingding Feng, Zhongxuan Ma, Fuquan Zhang   +5 more
openaire   +2 more sources

Blonanserin for schizophrenia: Systematic review and meta-analysis of double-blind, randomized, controlled trials

Journal of Psychiatric Research, 2013
Yuki Matsuda, Hiroshi Nakamura, Taro Kishi   +2 more
exaly  

Blonanserin/haloperidol/methylphenidate

Reactions Weekly, 2016
openaire   +1 more source

Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: Role of indirect 5-HT partial agonism

Behavioural Brain Research, 2013
H Y Meltzer
exaly